425: Arogo Capital Acquisition Corp. Faces Nasdaq Delisting Due to Non-Compliance with Listing Rules

Arogo Capital Acquisition Corp. received a delisting notice from Nasdaq for failing to meet minimum market value and total holder requirements and has requested a hearing to appeal the decision.

Summary

• Arogo Capital Acquisition Corp. received a notice from Nasdaq on July 31, 2024, indicating that its securities are subject to suspension and delisting.
• The delisting is due to non-compliance with Nasdaq Listing Rule 5450(b)(2)(A), requiring a minimum Market Value of Listed Securities of $50 million, and Nasdaq Listing Rule 5450(a)(2), requiring at least 400 total holders.
• Arogo has requested a hearing before the Nasdaq Hearing Panel to appeal the delisting determination and request additional time to regain compliance.
• The company paid a $20,000 fee and submitted the hearing request on August 6, 2024.
• Arogo expects the hearing request will stay any suspension or delisting action pending the hearing.
• There is no assurance that Arogo will be able to satisfy Nasdaq's continued listing requirements or maintain compliance with other Nasdaq listing requirements.
• Arogo is working on a proposed business combination transaction and intends to file a registration statement on Form F-4 with the SEC.
• The company's stockholders are advised to read the preliminary proxy statement/prospectus and the amendments thereto and the definitive proxy statement and documents incorporated by reference therein filed in connection with the proposed business combination transaction.
• The company is a blank check company aiming to acquire one or more businesses and assets via a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization.

Sentiment

Score: 3

Explanation: The sentiment is negative due to the delisting notice and uncertainty regarding the company's ability to regain compliance with Nasdaq listing requirements. The company is facing significant challenges.

Positives

• Arogo has requested a hearing to appeal the delisting determination, which should result in a stay of suspension pending the hearing.
• The company is pursuing a business combination, which could potentially improve its financial position and compliance with listing requirements.

Negatives

• Arogo received a delisting notice from Nasdaq due to non-compliance with listing rules regarding market value and total holders.
• There is no assurance that the company will be able to regain compliance with Nasdaq listing requirements.

Risks

• The company may not be able to satisfy Nasdaq's continued listing requirements.
• The company may not be able to regain compliance with Nasdaq Listing Rule 5450(b)(2)(A) and Nasdaq Listing Rule 5450(a)(2).
• The company may not be able to maintain compliance with other Nasdaq listing requirements.
• The company may not obtain a favorable decision from the Nasdaq Hearing Panel.
• The proposed business combination may not be consummated.

Future Outlook

The company is focused on regaining compliance with Nasdaq listing requirements and completing a business combination. The company is seeking additional time from the Nasdaq Hearing Panel to achieve these goals.

Management Comments

• The company expects that its timely hearing request will result in a stay of any suspension or delisting action pending the hearing.

Industry Context

SPACs like Arogo Capital Acquisition Corp. face increasing scrutiny and pressure to complete business combinations within specified timeframes. Failure to do so can lead to delisting and liquidation. Other SPACs that have faced similar challenges include companies that were unable to find suitable merger targets or failed to meet listing requirements post-merger.

Comparison to Industry Standards

• Many SPACs struggle to maintain listing compliance due to market volatility and difficulty in finding suitable merger targets.
• The $50 million market capitalization requirement is a common threshold for Nasdaq listing, and failure to meet this standard is a frequent cause for delisting notices.
• Companies like Digital World Acquisition Corp. (DWAC), another SPAC, have faced similar listing challenges and regulatory scrutiny related to their proposed mergers.
• Compared to industry benchmarks, Arogo's situation is not unique, as many SPACs formed in the 2020-2021 boom are now facing deadlines and potential delisting if they cannot complete a business combination.

Stakeholder Impact

• Shareholders face the risk of delisting, which could negatively impact the value of their investment.
• Employees may experience uncertainty regarding the company's future.
• The proposed business combination partner, Ayurcann Holding Corp., is also affected by the uncertainty surrounding Arogo's listing status.

Next Steps

• Arogo will attend a hearing before the Nasdaq Hearing Panel to appeal the delisting determination.
• The company will continue to pursue its proposed business combination transaction and file a registration statement on Form F-4 with the SEC.
• Arogo will work to regain compliance with Nasdaq listing requirements.

Key Dates